Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Enzinger, C; Fazekas, F; Matthews, PM; Ropele, S; Schmidt, H; Smith, S; Schmidt, R.
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.
NEUROLOGY. 2005; 64: 1704-1711.
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Enzinger Christian
Fazekas Franz
Ropele Stefan
Schmidt Helena
Schmidt Reinhold

Dimensions Citations:

Plum Analytics:
OBJECTIVES: To determine the rate of brain atrophy in neurologically asymptomatic elderly and to investigate the impact of baseline variables including conventional cerebrovascular risk factors, APOE epsilon4, and white matter hyperintensity (WMH) on its progression. METHODS: We assessed the brain parenchymal fraction at baseline and subsequent annual brain volume changes over 6 years for 201 participants (F/M = 96/105; 59.8 +/- 5.9 years) in the Austrian Stroke Prevention Study from 1.5-T MRI scans using SIENA (structural image evaluation using normalization of atrophy)/SIENAX (an adaptation of SIENA for cross-sectional measurement)( Hypertension, cardiac disease, diabetes mellitus, smoking, and regular alcohol intake were present in 64 (31.8%), 60 (29.9%), 5 (2.5%), 70 (39.3%), and 40 (20.7%) subjects, respectively. Plasma levels of fasting glucose (93.7 +/- 18.6 mg/dL), glycated hemoglobin A (HbA1c; 5.6 +/- 0.7%), total cholesterol (228.3 +/- 40.3 mg/dL), and triglycerides (127.0 +/- 75.2 mg/dL) were determined. WMH was rated as absent (n = 56), punctate (n = 120), early confluent (n = 14), and confluent (n = 11). RESULTS: The baseline brain parenchymal fraction of the entire cohort was 0.80 +/- 0.02 with a mean annual brain volume change of -0.40 +/- 0.29%. Univariate analysis demonstrated a higher rate of brain atrophy in older subjects (p = 0.0001), in those with higher HbA1c (p = 0.0001), higher body mass index (p = 0.02), high alcohol intake (p = 0.04), severe WMH (p = 0.03), and in APOE epsilon4 carriers (p = 0.07). Multivariate analysis suggested that baseline brain parenchymal fraction, HbA1c, and WMH score explain a major proportion of variance in the rates of brain atrophy in the cohort (corrected R2 = 0.27; p = 0.0001). CONCLUSIONS: Neurologically asymptomatic elderly experience continuing brain volume loss, which appears to accelerate with age. Glycated hemoglobin A (HbA1c) was identified as a risk factor for a greater rate of brain atrophy. Clustering of factors associated with the so-called metabolic syndrome in subjects with high HbA1c suggests a link between this syndrome and late-life brain tissue loss.
Find related publications in this database (using NLM MeSH Indexing)
Age Distribution -
Aged -
Aging - pathology
Atrophy - blood
Austria - epidemiology
Brain - metabolism
Cohort Studies - metabolism
Disease Progression - metabolism
Female - metabolism
Follow-Up Studies - metabolism
Hemoglobin A, Glycosylated - analysis
Humans - analysis
Hyperglycemia - blood
Hyperlipidemias - blood
Magnetic Resonance Imaging - blood
Male - blood
Metabolic Syndrome X - blood
Middle Aged - blood
Predictive Value of Tests - blood
Reference Values - blood
Risk Factors - blood

© Med Uni Graz Impressum